MedPath
NMPA Approval

Ligustrazine Phosphate Injection

国药准字H22026488

August 10, 2020

Drug Information

磷酸川芎嗪注射液

注射剂

2ml:50mg

化学药品

August 10, 2020

Company Information

Applicant Company

吉林省梅河口市建国路4555号

Manufacturing Company

吉林省梅河口市建国路4555号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸川芎嗪注射液 - NMPA 批准文号 | MedPath